Liu_2022_Chem.Commun.(Camb)__

Reference

Title : An esterase-activatable curcumin prodrug for tumor-targeting therapy - Liu_2022_Chem.Commun.(Camb)__
Author(s) : Liu L , Zhang L , Tao M , Wang M , Dong L , Hai Z
Ref : Chem Commun (Camb) , : , 2022
Abstract :

A tumor-targeting therapy strategy is urgently needed to increase the accumulation of drugs in tumors and reduce the side effects in normal tissues. Herein, we developed an esterase-activatable curcumin prodrug Cur-RGD for tumor-targeting therapy. Armed with the tumor-targeting RGD peptide and in situ esterase-triggered drug release, this prodrug Cur-RGD can efficiently improve the therapeutic effect of curcumin in tumors.

PubMedSearch : Liu_2022_Chem.Commun.(Camb)__
PubMedID: 36373630

Related information

Citations formats

Liu L, Zhang L, Tao M, Wang M, Dong L, Hai Z (2022)
An esterase-activatable curcumin prodrug for tumor-targeting therapy
Chem Commun (Camb) :

Liu L, Zhang L, Tao M, Wang M, Dong L, Hai Z (2022)
Chem Commun (Camb) :